Europe Diabetic Foot Ulcer Treatment Market Trends and Forecast 2034
Europe Diabetic Foot Ulcer Treatment Market Size- By Treatment, By Type, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Aug-2025 | Report ID: HLCA25257 | Pages: 1 - 273 | Formats*: |
| Category : Healthcare | |||
Europe Diabetic Foot Ulcer Treatment Market Introduction and Overview
According to SPER Market Research, the Europe Diabetic Foot Ulcer Treatment Market is estimated to reach USD 2.97 billion by 2034 with a CAGR of 5.88%.
The report includes an in-depth analysis of the Europe Diabetic Foot Ulcer Treatment Market, including market size and trends, product mix, Applications, and supplier analysis. The Europe Diabetic Foot Ulcer Treatment Market was valued at USD 1.69 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.88% between 2025 and 2034. The market is experiencing significant growth due to the rising prevalence of foot ulcers among diabetic patients, increasing ischemic ulcer cases, and a growing diabetic population vulnerable to complications. In Europe, the surge in diabetes cases is directly linked to a higher incidence of diabetic foot ulcers. Additionally, the aging population is a major driver, as older adults are more susceptible to type 2 diabetes and its complications. As life expectancy increases, so does the demand for effective diabetic foot care tailored to the elderly. Technological advancements in treatment and management further contribute to the market’s expansion and evolving healthcare needs.
By Type:
The neuro-ischemic ulcer segment currently leads the market and is expected to maintain its dominance in the coming years. These ulcers, caused by both nerve damage and poor blood circulation, require specialized treatments involving advanced wound care solutions and therapeutic devices. Innovations like bioengineered tissues, growth factor therapies, and enhanced dressing materials are increasingly used to support healing. Additionally, the adoption of vascular interventions and personalized treatment strategies is driving demand. Meanwhile, the neuropathic ulcer segment is poised for rapid growth, supported by the rising diabetes prevalence in Europe and advancements in targeted therapies designed to address nerve-related complications.
By Treatment:
The biologics segment led the market due to rising demand for advanced treatments like growth factors, skin substitutes, stem cell therapy, and collagen products. These therapies aid healing in chronic wounds by promoting angiogenesis and reducing inflammation. Despite cost and access challenges, their integration with standard care enhances outcomes. Meanwhile, the therapy devices segment is set for rapid growth, driven by non-invasive tools like NPWT and oxygen therapy. Increased awareness and innovation are fueling adoption, despite challenges in training and patient compliance.
By End User:
The homecare segment held the largest market share in 2024 and is projected to grow at the fastest rate during the forecast period. This growth is driven by enhanced patient comfort and convenience, which support better adherence to treatment and improved clinical outcomes. Homecare is often more cost-effective than hospital-based care, easing the financial burden on both patients and healthcare systems. The integration of telehealth enables ongoing monitoring and virtual consultations, while patient education on wound care and diabetes management promotes active participation in treatment and long-term care success.
Regional Insights
The diabetic foot ulcer treatment market in the UK holds a notable position, supported by a well-established healthcare system and growing cases of foot ulcers among diabetic patients. Increased awareness and medical advancements continue to drive market growth. In Germany, the market is expanding due to the frequent recurrence of diabetic foot ulcers, prompting a strong demand for effective and long-term treatment solutions. In France, growth is fueled by ongoing technological innovations and a rising prevalence of diabetes, emphasizing the need for advanced care strategies and making diabetic foot management a key focus within the country’s healthcare landscape.
Market Competitive Landscape
The Europe Diabetic Foot Ulcer Treatment Market is moderately fragmented. Some key players are ConvaTec Group PLC, Acelity L.P. Inc., 3M Health Care, Coloplast Corp., Smith & Nephew Plc., B. Braun SE, Medline Industries, LP, Organogenesis, Inc., Molnlycke Health Care AB, Medtronic.
Recent Developments:
In October 2024, Mölnlycke Health Care AB, a global leader in the MedTech industry with a focus on wound care and management, announced the successful acquisition of P.G.F. Industry Solutions GmbH. P.G.F. is renowned for its Granudacyn product line, which offers advanced solutions for wound cleansing and moistening.
In October 2024, Mölnlycke Health Care AB acquired P.G.F. Industry Solutions GmbH, known for its Granudacyn wound cleansing and moistening products, strengthening its position in advanced wound care.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Treatment, By Type, By End Use |
| Regions covered | France, Germany, Italy, Spain, United Kingdom Rest of Europe |
| Companies Covered | ConvaTec Group PLC, Acelity L.P. Inc., 3M Health Care, Coloplast Corp., Smith & Nephew Plc., B. Braun SE, Medline Industries, LP, Organogenesis, Inc., Molnlycke Health Care AB, Medtronic. |
Key Topics Covered in the Report
- Europe Diabetic Foot Ulcer Treatment Market Size (FY’2021-FY’2034)
- Overview of Europe Diabetic Foot Ulcer Treatment Market
- Segmentation of Europe Diabetic Foot Ulcer Treatment Market By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others)
- Segmentation of Europe Diabetic Foot Ulcer Treatment Market By Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-ischemic Ulcers)
- Segmentation of Europe Diabetic Foot Ulcer Treatment Market By End-use (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare)
- Statistical Snap of Europe Diabetic Foot Ulcer Treatment Market
- Expansion Analysis of Europe Diabetic Foot Ulcer Treatment Market
- Problems and Obstacles in Europe Diabetic Foot Ulcer Treatment Market
- Competitive Landscape in the Europe Diabetic Foot Ulcer Treatment Market
- Details on Current Investment in Europe Diabetic Foot Ulcer Treatment Market
- Competitive Analysis of Europe Diabetic Foot Ulcer Treatment Market
- Prominent Players in the Europe Diabetic Foot Ulcer Treatment Market
- SWOT Analysis of Europe Diabetic Foot Ulcer Treatment Market
- Europe Diabetic Foot Ulcer Treatment Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Europe Diabetic Foot Ulcer Treatment Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Diabetic Foot Ulcer Treatment Market
7.Europe Diabetic Foot Ulcer Treatment Market, By Treatment (USD Million) 2021-2034
7.1.Wound Care Dressings7.2.Biologics7.3.Therapy Devices7.4.Antibiotic Medications7.5.Others
8.Europe Diabetic Foot Ulcer Treatment Market, By Type (USD Million) 2021-2034
8.1.Neuropathic Ulcers8.2.Ischemic Ulcers8.3.Neuro-ischemic Ulcers
9.Europe Diabetic Foot Ulcer Treatment Market, By End-use (USD Million) 2021-2034
9.1.Hospitals and Clinics9.2.Ambulatory Surgical Centers9.3.Homecare (Others)
10.Europe Diabetic Foot Ulcer Treatment Market, (USD Million) 2021-2034
10.1.Europe Diabetic Foot Ulcer Treatment Market Size and Market Share
11.Europe Diabetic Foot Ulcer Treatment Market, By Region, (USD Million) 2021-2034
11.1.France11.2.Germany11.3.Italy11.4.Spain11.5.United Kingdom11.6.Rest of Europe
12.Company Profile
12.1.ConvaTec Group PLC
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2.Acelity L.P. Inc.
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3.3M Health Care
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4.Coloplast Corp.
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5.Smith & Nephew Plc.
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6.B. Braun SE
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7.Medline Industries, LP
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8.Organogenesis, Inc.
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9.Molnlycke Health Care AB
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10.Medtronic.
12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments
12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Europe Diabetic Foot Ulcer Treatment Market is projected to reach USD 2.97 billion by 2034, growing at a CAGR of 5.88% during the forecast period.
Europe Diabetic Foot Ulcer Treatment Market size from 2025. The Market is expected to reach USD 2.97 billion by 2034, at a CAGR of 5.88% during the forecast period.
Europe Diabetic Foot Ulcer Treatment Market CAGR of 5.88% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Europe Diabetic Foot Ulcer Treatment Market size is USD 2.97 billion from 2025 to 2034.
Europe Diabetic Foot Ulcer Treatment Market covered By Treatment, By Type, By End Use
The North America is anticipated to have the highest Market share in the Europe Diabetic Foot Ulcer Treatment Market.
ConvaTec Group PLC, Acelity L.P. Inc., 3M Health Care, Coloplast Corp., Smith & Nephew Plc., B. Braun SE, Medline Industries, LP, Organogenesis, Inc., Molnlycke Health Care AB, Medtronic.
The report includes an in-depth analysis of the Europe Diabetic Foot Ulcer Treatment Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
